Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

AC Immune SA (ACIU)

https://www.acimmune.com

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/23/2016

Market Cap

339,910,164

Shares Outstanding

98,750,000

Weighted SO

98,801,407

Total Employees

N/A

Upcoming Earnings

08/02/2024

Similar Tickers

PMVP --.--%

ELYM --.--%

MNOV --.--%

PHVS --.--%

PEPG --.--%

RGNX --.--%

ANEB --.--%

IVVD --.--%

ABEO --.--%

Beta

1.2680

Last Div

0.0000

Range

2.2-5.14

Chg

0.0200

Avg Vol

276246

Mkt Cap

339910164

Exch

NASDAQ

Country

CH

Phone

41 21 345 91 21

DCF Diff

2.7876

DCF

0.6530

Div Yield

0.0000

P/S

19.0322

EV Multiple

-4.2189

P/FV

2.3851

Div Yield %

0.0000

P/E

-4.8651

PEG

-0.1969

Payout

0.0000

Current Ratio

1.7959

Quick Ratio

1.7959

Cash Ratio

0.5129

DSO

9.4738

DIO

0.0000

Op Cycle

9.4738

DPO

8.8246

CCC

0.6492

Gross Margin

-2.8323

Op Margin

-3.8763

Pretax Margin

-3.9066

Net Margin

-3.9068

Eff Tax Rate

-0.0007

ROA

-0.2547

ROE

-0.4366

ROCE

-0.4382

NI/EBT

1.0001

EBT/EBIT

1.0078

EBIT/Rev

-3.8763

Debt Ratio

0.0107

D/E

0.0206

LT Debt/Cap

0.0202

Total Debt/Cap

0.0202

Int Coverage

-682.2273

CF/Debt

-11.1987

Equity Multi

1.9245

Rec Turnover

38.5274

Pay Turnover

41.3617

Inv Turnover

0.0000

FA Turnover

2.5139

Asset Turnover

0.0652

OCF/Share

-0.2860

FCF/Share

-0.2929

Cash/Share

1.7592

OCF/Sales

-1.8380

FCF/OCF

1.0244

CF Coverage

-11.1987

ST Coverage

0.0000

CapEx Coverage

-40.9597

Div&CapEx Cov

-40.9597

P/BV

2.3851

P/B

2.3851

P/S

19.0322

P/E

-4.8651

P/FCF

-10.1080

P/OCF

-10.3412

P/CF

-10.3412

PEG

-0.1969

P/S

19.0322

EV Multiple

-4.2189

P/FV

2.3851

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Aug 15, 21:27 Rezolve AI Limited Closes Business Combination with Armada Acquisition Corp. I; Announces Date for Commencement of Trading on the Nasdaq; Launching one of the first pure play Ai companies with its own foundation Large Language Model - brainpowa GlobeNewswire Inc. Dec 15, 07:56 AC Immune Announces Pricing of Underwritten Offering of Common Shares GlobeNewswire Inc. Dec 15, 07:22 AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial

Revenue Product Segmentation